Howard Hughes Medical Institute’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Howard Hughes Medical Institute’s Portfolio ALXA Stock Details ALXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-98,914	Closed	-$122K	–	193
2015 Q3	$122K	Hold	98,914	–	–	0.02%	133
2015 Q2	$108K	Hold	98,914	–	–	0.02%	144
2015 Q1	$205K	Hold	98,914	–	–	0.03%	127
2014 Q4	$147K	Hold	98,914	–	–	0.04%	132
2014 Q3	$230K	Hold	98,914	–	–	0.05%	115
2014 Q2	$452K	Hold	98,914	–	–	0.08%	61
2014 Q1	$438K	Hold	98,914	–	–	0.06%	50
2013 Q4	$468K	Hold	98,914	–	–	0.07%	55
2013 Q3	$506K	Hold	98,914	–	–	0.08%	52
2013 Q2	$429K	Buy	+98,914	New	+$448K	0.14%	62

Other funds holding ALXA

LPA

Lansdowne Partners Austria Vienna, Austria $29M AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CLOS

Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return

Howard Hughes Medical Institute's ALXA Position: Q4 2015 in Review

Howard Hughes Medical Institute sold out of Alexza Pharmaceuticals Inc (ALXA) in Q4 2015, closing a stake of 98,914 shares — an estimated $122K sold.

Howard Hughes Medical Institute first reported a position in ALXA in Q2 2013 and held it in 10 quarters. The position peaked at $506K in Q3 2013. 26 funds tracked by Wall St. Rank hold ALXA as of Q4 2015.

Howard Hughes Medical Institute reported no remaining Alexza Pharmaceuticals Inc position as of Q4 2015 after selling out during the quarter.
Howard Hughes Medical Institute sold 98,914 Alexza Pharmaceuticals Inc shares in Q4 2015, an estimated $122K.
Howard Hughes Medical Institute first reported a position in Alexza Pharmaceuticals Inc in Q2 2013 and held it in 10 quarters.
Howard Hughes Medical Institute's Alexza Pharmaceuticals Inc position peaked at $506K in Q3 2013.
26 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q4 2015.

Based on Howard Hughes Medical Institute's 13F filing for Q4 2015, filed 11 Feb 2016.